Amgen's total assets for Q1 2024 were $92.98B, a decrease of -4.30% from the previous quarter. GB:0R0T total liabilities were $87.96B for the fiscal quarter, a -3.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.